Natural Immunity Longer Lasting Than Protection From COVID-19 Vaccines: Dr. Robert Malone Byand
The immunity conferred by recovering from COVID-19 is better than the protection afforded by COVID-19 vaccines, a prominent vaccine inventor says, citing in part a recent study from Israel.
Israeli researchers found that people in the country vaccinated with Pfizer’s COVID-19 shot were 13 times more likely to contract the Delta variant of the CCP virus and 27 times more at risk of symptomatic disease, compared to those who had recovered from COVID-19.
“It’s now been shown in that paper and others that the breadth of that immune response in terms of T and B cell memory populations is more diverse and more long-lasting than the breadth of immune response elicited by the spike-based vaccines alone,” Dr. Robert Malone, the inventor of the class of vaccines based on messenger RNA, said on Epoch TV’s “American Thought Leaders” program.
“Even if we had 100% vaccine uptake with these vaccines…we would not be able to stop the spread of the virus through the US population. We would slow it.”
— American Thought Leaders 🇺🇸 with @JanJekielek (@AmThoughtLeader) September 3, 2021
While antibodies reduce over time, T cells, a type of white blood cells that protect against infection, and B cells can last for a lifetime.
Federal health authorities acknowledge natural immunity exists but have continued to claim that the protection from vaccines is better, pointing to a different set of studies, including one from Kentucky published by state and Centers for Disease Control and Prevention (CDC) researchers.
Authorities continue to urge everybody, regardless of prior infection, to get a vaccine.
Some other scientists, though, say the growing body of evidence on natural immunity must play a larger role in policy discussions on vaccination amid the pandemic.
“Natural immunity is pretty darn good. We would be best to focus our efforts on people who are both unvaccinated AND have not recovered from prior infection,” Dr. Vinay Prasad, a professor at the University of California–San Francisco’s Department of Epidemiology & Biostatistics, wrote on social media over the weekend.